Decoding Trump 2.0: The Global Ripple Effect on Biotech and Medtech in Asia

​📣 Join Us for a Timely Industry Dialogue

​As sweeping policy shifts unfold under the second Trump administration, Asia’s biotech and medtech sectors are facing a new wave of geopolitical and regulatory uncertainty. How will these developments impact innovation, market expansion, and compliance across the region? And how can Asia-based companies future-proof their go-to-market strategies in an increasingly volatile global landscape?

​Biotech Connection Singapore (BCS), in collaboration with APACMed and Geneo at Singapore Science Park, is proud to present a panel discussion and networking event exploring these critical questions.

​Decoding Trump 2.0: The Global Ripple Effect on Biotech and Medtech in Asia
🗓 Date: Tuesday, 20 May 2025
🕔 Time: 5:00 – 8:00 PM
📍 Venue: Metro @  Bridge+, 2 Science Park Drive, Ascent, Level 1, Singapore 118222

​🎤 Opening Speaker & Panel Moderator:

​Sejal Mistry – Director, Crowell Global Advisors

​💡 Panel Speakers:

​Stephen Lim – CEO, FathomX

​Vishal Doshi – Founder & CEO, AUM Biosciences

​Michael Ma – CEO, MedAsian Group

​🤝 Don’t miss this opportunity to connect with industry leaders and explore how Asia’s biotech and medtech players are adapting and thriving in a rapidly evolving global landscape.